Works matching AU Abe, Masakazu

Results: 66
    1
    2
    3
    4
    5
    6

    Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.

    Published in:
    Cancer Science, 2022, v. 113, n. 1, p. 240, doi. 10.1111/cas.15185
    By:
    • Shoji, Tadahiro;
    • Enomoto, Takayuki;
    • Abe, Masakazu;
    • Okamoto, Aikou;
    • Nagasawa, Takayuki;
    • Oishi, Tetsuro;
    • Nagase, Satoru;
    • Mori, Masahiko;
    • Inokuchi, Yuki;
    • Kamiura, Shoji;
    • Komiyama, Shinichi;
    • Takeshima, Nobuhiro;
    • Sugiyama, Toru
    Publication type:
    Article
    7

    Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 11, p. 2213, doi. 10.1111/cas.13381
    By:
    • Nishio, Shin;
    • Takekuma, Munetaka;
    • Takeuchi, Satoshi;
    • Kawano, Kouichirou;
    • Tsuda, Naotake;
    • Tasaki, Kazuto;
    • Takahashi, Nobutaka;
    • Abe, Masakazu;
    • Tanaka, Aki;
    • Nagasawa, Takayuki;
    • Shoji, Tadahiro;
    • Xiong, Hao;
    • Nuthalapati, Silpa;
    • Leahy, Terri;
    • Hashiba, Hideyuki;
    • Kiriyama, Tsukasa;
    • Komarnitsky, Philip;
    • Hirashima, Yasuyuki;
    • Ushijima, Kimio
    Publication type:
    Article
    8

    Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial.

    Published in:
    2016
    By:
    • Abe, Masakazu;
    • Hirashima, Yasuyuki;
    • Kasamatsu, Yuka;
    • Kado, Nobuhiro;
    • Komeda, Satomi;
    • Kuji, Shiho;
    • Tanaka, Aki;
    • Takahashi, Nobutaka;
    • Takekuma, Munetaka;
    • Hihara, Hanako;
    • Ichikawa, Yoshikazu;
    • Itonaga, Yui;
    • Hirakawa, Tomoko;
    • Nasu, Kaei;
    • Miyagi, Kanoko;
    • Murakami, Junko;
    • Ito, Kimihiko
    Publication type:
    journal article
    9

    Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.

    Published in:
    Supportive Care in Cancer, 2014, v. 22, n. 11, p. 2891, doi. 10.1007/s00520-014-2280-6
    By:
    • Takeshima, Nobuhiro;
    • Matoda, Maki;
    • Abe, Masakazu;
    • Hirashima, Yasuyuki;
    • Kai, Kentaro;
    • Nasu, Kaei;
    • Takano, Masashi;
    • Furuya, Kenichi;
    • Sato, Seiya;
    • Itamochi, Hiroaki;
    • Tsubamoto, Hiroshi;
    • Hasegawa, Kosei;
    • Terao, Kiminari;
    • Otsuki, Takeo;
    • Kuritani, Keiko;
    • Ito, Kimihiko
    Publication type:
    Article
    10
    11

    A case of small intestinal endometrioid adenocarcinoma.

    Published in:
    Surgical Case Reports, 2016, v. 2, n. 1, p. 1, doi. 10.1186/s40792-016-0226-6
    By:
    • Ogi, Yusuke;
    • Yamaguchi, Tomohiro;
    • Kinugasa, Yusuke;
    • Shiomi, Akio;
    • Kagawa, Hiroyasu;
    • Yamakawa, Yushi;
    • Numata, Masakatsu;
    • Furutani, Akinobu;
    • Abe, Masakazu
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.

    Published in:
    2022
    By:
    • Yamamoto, Senri;
    • Iihara, Hirotoshi;
    • Uozumi, Ryuji;
    • Kawazoe, Hitoshi;
    • Tanaka, Kazuki;
    • Fujita, Yukiyoshi;
    • Abe, Masakazu;
    • Imai, Hisao;
    • Karayama, Masato;
    • Hayasaki, Yoh;
    • Hirose, Chiemi;
    • Suda, Takafumi;
    • Nakamura, Kazuto;
    • Suzuki, Akio;
    • Ohno, Yasushi;
    • Morishige, Ken-ichirou;
    • Inui, Naoki
    Publication type:
    journal article
    22
    23
    24

    Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2-IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review.

    Published in:
    International Journal of Clinical Oncology, 2014, v. 19, n. 2, p. 341, doi. 10.1007/s10147-013-0551-8
    By:
    • Kuji, Shiho;
    • Hirashima, Yasuyuki;
    • Komeda, Satomi;
    • Tanaka, Aki;
    • Abe, Masakazu;
    • Takahashi, Nobutaka;
    • Takekuma, Munetaka;
    • Asakura, Hirofumi;
    • Harada, Hideyuki;
    • Nishimura, Tetsuo
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 10, p. 950, doi. 10.1093/jjco/hyy114
    By:
    • Hashimoto, Hironobu;
    • Abe, Masakazu;
    • Yanai, Takako;
    • Yamaguchi, Takuhiro;
    • Zenda, Sadamoto;
    • Uchitomi, Yosuke;
    • Fukuda, Haruhiko;
    • Mori, Mikio;
    • Iwasa, Satoru;
    • Yamamoto, Noboru
    Publication type:
    Article
    34
    35
    36

    Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    2025
    By:
    • Murakami, Michiyasu;
    • Miyata, Yoshiharu;
    • Nakashima, Kazuhisa;
    • Abe, Masakazu;
    • Nishimura, Junichi;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakamura, Naoki;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    37

    Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

    Published in:
    2025
    By:
    • Nakashima, Kazuhisa;
    • Harashima, Saki;
    • Kaneko, Rena;
    • Tanaka, Ryuhei;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    38

    Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
    By:
    • Hayashi, Toshinobu;
    • Yamamoto, Shun;
    • Miyata, Yoshiharu;
    • Takeda, Masayuki;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    39

    Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
    By:
    • Kobayashi, Masamitsu;
    • Kako, Jun;
    • Iba, Arisa;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    40

    2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
    By:
    • Iihara, Hirotoshi;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi;
    • Higashi, Takahiro;
    • Boku, Narikazu
    Publication type:
    Article
    41
    42

    Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.

    Published in:
    Hepatology Research, 2023, v. 53, n. 10, p. 1008, doi. 10.1111/hepr.13933
    By:
    • Kurebayashi, Yutaka;
    • Tsujikawa, Hanako;
    • Sugimoto, Katsutoshi;
    • Yunaiyama, Daisuke;
    • Araki, Yoichi;
    • Saito, Kazuhiro;
    • Takahashi, Hiroshi;
    • Kakegawa, Tatsuya;
    • Wada, Takuya;
    • Tomita, Yusuke;
    • Abe, Masakazu;
    • Yoshimasu, Yu;
    • Takeuchi, Hirohito;
    • Hirata, Taiki;
    • Sakamaki, Kentaro;
    • Kakimi, Kazuhiro;
    • Nagao, Toshitaka;
    • Itoi, Takao;
    • Sakamoto, Michiie
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50